Seung-Jeong Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Seung-Jeong Yang has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Dong Chul Kim
Department of Korean Medicine Obstetrics & Gynecology Ilsan Dong-Guk University Korean Medicine Hospital Gyeonggi-do Republic of Korea
2 shared publications - Jeong-Eun Yoo
Department of Obstetrics and Gynecology, College of Korean Medicine, Daejeon University, Daejeon 35235, Korea
2 shared publications - Chang-Hoon Lee
Department of Korean Medicine Gynecology, Kyung Hee University Korean Medicine Hospital at Gangdong, Seoul, Korea
1 shared publication - Chang-Min Choi
Department of Korean Gynecology, College of Korean Medicine, Wonkwang University, Iksan, Republic of Korea
1 shared publication - ChangJu Ryu
Ajoo communications co
1 shared publication - Deok-Sang Hwang
Department of Clinical Korean Medicine, Graduate School, Kyung Hee University, Seoul, Republic of Korea
1 shared publication
Latest Publications
- Open Access
- 1 December 2023
- Published by The Society of Korean Medicine in Journal of Korean Medicine
- Vol. 44 (4) , 121-135
Fetal safety of medicinal herbs and food ingredients during pregnancy: Recommendations from traditional Korean medicine based on expert opinions
Objectives: This study aimed to establish and provide reliable information for general public, based on expert consensus, on the risks of misuse of medicinal herbs for food and pure food ingredients for the fetus during pregnancy.Methods: A panelist of seven traditional Korean medicine (TKM) gynecologists responded to a questionnaire summarizing the fetal safety literature for twenty-five medicinal herbs for food and pure food ingredients derived from medicated diet (藥膳, Yaksun) recipes during three online Delphi rounds anonymously.Results: Ginkgonis Semen (Ginkgo nut), Illici Veri Fructus (Star anise), lavender, bitter gourd, and parsley were agreed at the level 1 of “Do not consume”. These five ingredients were recognized as having significant risks both in the literature evidence and in expert opinion. Rosemary, Citri Unshius Pericarpium, Discoreae Rhizoma, lemongrass, Schisandrae Fructus, Cassiae Semen, Foeniculi Fructus, Mori Fructus, Cinnamomi Cortex, and Astragali Radix were agreed at the level 2 of “consultation with TKM practitioner is required”.Conclusion: Based on the consensus of a seven-member expert panel of TKM gynecologists, consumption of Ginkgonis Semen (Ginkgo nut), Illici Veri Fructus (Star anise), lavender, bitter gourd, and parsley should be avoided by pregnant women. For Rosemary, Citri Unshius Pericarpium, Discoreae Rhizoma, lemongrass, Schisandrae Fructus, Cassiae Semen, Foeniculi Fructus, Mori Fructus, Cinnamomi Cortex, and Astragali Radix, the level 2 advisory may be recommended to use with caution and to consult a TKM practitioner for advice on consumption, dose, and duration.
- 1 December 2023
- Published by The Society of Korean Medicine in Journal of Korean Medicine
- Vol. 44 (4) , 121-135
Open AccessFetal safety of medicinal herbs and food ingredients during pregnancy: Recommendations from traditional Korean medicine based on expert opinions
Objectives: This study aimed to establish and provide reliable information for general public, based on expert consensus, on the risks of misuse of medicinal herbs for food and pure food ingredients for the fetus during pregnancy.Methods: A panelist of seven traditional Korean medicine (TKM) gynecologists responded to a questionnaire summarizing the fetal safety literature for twenty-five medicinal herbs for food and pure food ingredients derived from medicated diet (藥膳, Yaksun) recipes during three online Delphi rounds anonymously.Results: Ginkgonis Semen (Ginkgo nut), Illici Veri Fructus (Star anise), lavender, bitter gourd, and parsley were agreed at the level 1 of “Do not consume”. These five ingredients were recognized as having significant risks both in the literature evidence and in expert opinion. Rosemary, Citri Unshius Pericarpium, Discoreae Rhizoma, lemongrass, Schisandrae Fructus, Cassiae Semen, Foeniculi Fructus, Mori Fructus, Cinnamomi Cortex, and Astragali Radix were agreed at the level 2 of “consultation with TKM practitioner is required”.Conclusion: Based on the consensus of a seven-member expert panel of TKM gynecologists, consumption of Ginkgonis Semen (Ginkgo nut), Illici Veri Fructus (Star anise), lavender, bitter gourd, and parsley should be avoided by pregnant women. For Rosemary, Citri Unshius Pericarpium, Discoreae Rhizoma, lemongrass, Schisandrae Fructus, Cassiae Semen, Foeniculi Fructus, Mori Fructus, Cinnamomi Cortex, and Astragali Radix, the level 2 advisory may be recommended to use with caution and to consult a TKM practitioner for advice on consumption, dose, and duration.
- Open Access
- 27 December 2021
- Published by Society for Meridian and Acupoint in Korean Journal of Acupuncture
- Vol. 38 (4) , 267-274
A Development of an Acupoints Education Table using 3D Technology and Augmented Reality
SeungJeong Yang, ChangJu Ryu, SangCheol Kim, JaeSouk Kim. Korean J Acupunct 2021;38:267-74. https://doi.org/10.14406/acu.2021.036
- 27 December 2021
- Published by Society for Meridian and Acupoint in Korean Journal of Acupuncture
- Vol. 38 (4) , 267-274
Open AccessA Development of an Acupoints Education Table using 3D Technology and Augmented Reality
SeungJeong Yang, ChangJu Ryu, SangCheol Kim, JaeSouk Kim. Korean J Acupunct 2021;38:267-74. https://doi.org/10.14406/acu.2021.036
- Open Access
- 1 September 2021
- Published by Elsevier in Integrative Medicine Research
- Vol. 10 (3) , 100706
Prescription patterns of herbal medicine for menopausal disorders in major Korean medicine hospitals: A multicenter retrospective study
- 1 September 2021
- Published by Elsevier in Integrative Medicine Research
- Vol. 10 (3) , 100706
Open AccessPrescription patterns of herbal medicine for menopausal disorders in major Korean medicine hospitals: A multicenter retrospective study
- Open Access
- 1 December 2018
- Published by MDPI AG in Pharmaceutics
- Vol. 10 (4) , 253
Pharmacokinetic Profile of Kaurenoic Acid after Oral Administration of Araliae Continentalis Radix Extract Powder to Humans
The objective of this study was to characterize pharmacokinetics (PKs) of kaurenoic acid (KAU) after administration of the clinical usual dose of Araliae Continentalis Radix extract powder to Korean subjects for the first time and evaluate the mechanism of its absorption in vitro. A simple, sensitive, and selective analytical method was developed for the detection of KAU in human plasma. Concentrations of KAU were quantified by ultra-performance liquid chromatography tandem mass spectrometry after simple liquid–liquid extraction. This pharmacokinetic model of KAU was best described by a two-compartment model with first-order absorption. To identify efflux transporters involved in the absorption of KAU, a Caco-2 monolayer model was used. Estimated PK parameters were: systemic clearance, 23.89 L/h; inter-compartmental clearance, 15.55 L/h; rate constant for absorption, 1.72 h−1; volume of distribution of the central compartment, 24.44 L; and volume of distribution of the peripheral compartment, 64.05 L. Results from Caco-2 bidirectional transport study suggested that KAU was a potential substrate of efflux transporters. In summary, PKs of KAU were successfully characterized after administration of a usual dose of Araliae continentalis Radix extract powder in human with the newly developed bioanalytical method and the mechanism of absorption of KAU was identified clearly.
- 1 December 2018
- Published by MDPI AG in Pharmaceutics
- Vol. 10 (4) , 253
Open AccessPharmacokinetic Profile of Kaurenoic Acid after Oral Administration of Araliae Continentalis Radix Extract Powder to Humans
The objective of this study was to characterize pharmacokinetics (PKs) of kaurenoic acid (KAU) after administration of the clinical usual dose of Araliae Continentalis Radix extract powder to Korean subjects for the first time and evaluate the mechanism of its absorption in vitro. A simple, sensitive, and selective analytical method was developed for the detection of KAU in human plasma. Concentrations of KAU were quantified by ultra-performance liquid chromatography tandem mass spectrometry after simple liquid–liquid extraction. This pharmacokinetic model of KAU was best described by a two-compartment model with first-order absorption. To identify efflux transporters involved in the absorption of KAU, a Caco-2 monolayer model was used. Estimated PK parameters were: systemic clearance, 23.89 L/h; inter-compartmental clearance, 15.55 L/h; rate constant for absorption, 1.72 h−1; volume of distribution of the central compartment, 24.44 L; and volume of distribution of the peripheral compartment, 64.05 L. Results from Caco-2 bidirectional transport study suggested that KAU was a potential substrate of efflux transporters. In summary, PKs of KAU were successfully characterized after administration of a usual dose of Araliae continentalis Radix extract powder in human with the newly developed bioanalytical method and the mechanism of absorption of KAU was identified clearly.